Physician profile
Dabo Liu
NPI 1285174094
$1,853.65
in general payments reported to CMS, 2019-2025
13 companies · $36.81 in 2025
The $36.81 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $125 · 2021: $415 · 2022: $625 · 2023: $638 · 2024: $13.61 · 2025: $36.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $375.01 | 2022-2023 | Austedo Xr |
| Gilead Sciences, INC. | $222.22 | 2021-2024 | Vemlidy |
| Abbvie INC. | $220.47 | 2020-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.73 | 2020-2025 | Jardiance |
| Genzyme Corporation | $145.70 | 2023 | |
| Neurocrine Biosciences, INC. | $125.00 | 2022 | |
| Novo Nordisk INC | $125.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2022 | |
| Amgen INC. | $112.76 | 2021-2025 | Repatha |
| Lilly USA, LLC | $93.50 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $76.55 | 2021 | |
| Amarin Pharma, INC. | $56.71 | 2021 | |
| Esperion Therapeutics, INC. | $20.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dabo Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.